AR116898A1 - DERIVADOS DE ARILSULFONILPIRROLCARBOXAMIDA COMO ACTIVADORES DE CANALES DE POTASIO Kv3 - Google Patents
DERIVADOS DE ARILSULFONILPIRROLCARBOXAMIDA COMO ACTIVADORES DE CANALES DE POTASIO Kv3Info
- Publication number
- AR116898A1 AR116898A1 ARP190103138A ARP190103138A AR116898A1 AR 116898 A1 AR116898 A1 AR 116898A1 AR P190103138 A ARP190103138 A AR P190103138A AR P190103138 A ARP190103138 A AR P190103138A AR 116898 A1 AR116898 A1 AR 116898A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- alkyl
- alkoxy
- chlorine
- halogen
- Prior art date
Links
- 102000004536 Shaw Potassium Channels Human genes 0.000 title abstract 2
- 108010017604 Shaw Potassium Channels Proteins 0.000 title abstract 2
- 239000012190 activator Substances 0.000 title abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 5
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 3
- 229910052801 chlorine Inorganic materials 0.000 abstract 3
- 239000000460 chlorine Substances 0.000 abstract 3
- 229910052731 fluorine Inorganic materials 0.000 abstract 3
- 239000011737 fluorine Substances 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 125000004428 fluoroalkoxy group Chemical group 0.000 abstract 2
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 125000006163 5-membered heteroaryl group Chemical group 0.000 abstract 1
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- IFVNUXHSZAILEA-UHFFFAOYSA-N N-sulfonyl-1H-pyrrole-3-carboxamide Chemical compound S(=O)(=O)=NC(=O)C1=CNC=C1 IFVNUXHSZAILEA-UHFFFAOYSA-N 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 238000006798 ring closing metathesis reaction Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 125000004001 thioalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Compuestos derivados de sulfonil-(1H)-pirrol-3-carboxamida como activadores del canal de potasio Kv3, composición farmacéutica que los comprende y el uso de los mismos para el tratamiento de trastornos neurológicos o psiquiátricos como así también del dolor crónico. Reivindicación 1: Un compuesto (I) de fórmula (1); donde R¹ se selecciona del grupo constituido por H, alquilo C₁₋₄, fluoroalquilo C₁₋₄, alcoxi C₁₋₄, fluoroalcoxi C₁₋₄, cicloalquilo C₃₋₈, tioalquilo C₁₋₄, tiofluoroalquilo C₁₋₄ y halógeno, en particular flúor y cloro; R² y R⁶ se seleccionan independientemente del grupo constituido por H, alquilo C₁₋₄, alcoxi C₁₋₄ y halógeno, en particular flúor y cloro; R³ se selecciona del grupo constituido por H, flúor y alquilo C₁₋₄; R⁴ y R⁵ se seleccionan del grupo constituido por H y flúor; R⁷ se selecciona del grupo constituido por H, alquilo C₁₋₄, halógeno, tal como flúor y cloro, alcoxi C₁₋₄, fluoroalquilo, fluoroalcoxi y alquil C₁₋₄amino; Y se selecciona del grupo constituido por oxígeno y azufre; HetAr se selecciona del grupo constituido por heteroarilo de 5 miembros, heteroarilo de 6 miembros y un sistema anular heteroaromático bicíclico y HetAr puede estar sustituido con uno o más sustituyentes R⁷ seleccionados independientemente; cuando R¹ es alcoxi C₁₋₄ puede formar un cierre anular con R² o R⁶ cuando uno cualquiera de estos es alquilo C₁₋₄; o una sal farmacéuticamente aceptable de este.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201800787 | 2018-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR116898A1 true AR116898A1 (es) | 2021-06-23 |
Family
ID=70327875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190103138A AR116898A1 (es) | 2018-10-30 | 2019-10-29 | DERIVADOS DE ARILSULFONILPIRROLCARBOXAMIDA COMO ACTIVADORES DE CANALES DE POTASIO Kv3 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20200131156A1 (es) |
| EP (1) | EP3873891A1 (es) |
| JP (1) | JP2022509416A (es) |
| KR (1) | KR20210086661A (es) |
| CN (1) | CN113056461A (es) |
| AR (1) | AR116898A1 (es) |
| AU (1) | AU2019373367A1 (es) |
| BR (1) | BR112020013011A2 (es) |
| CA (1) | CA3116273A1 (es) |
| CL (1) | CL2021001123A1 (es) |
| CO (1) | CO2021005579A2 (es) |
| CR (1) | CR20210285A (es) |
| DO (1) | DOP2021000081A (es) |
| EA (1) | EA202190899A1 (es) |
| EC (1) | ECSP21038534A (es) |
| IL (1) | IL282639A (es) |
| JO (1) | JOP20210091A1 (es) |
| MA (1) | MA54061A (es) |
| MX (1) | MX2021004935A (es) |
| PE (1) | PE20211975A1 (es) |
| PH (1) | PH12021550957A1 (es) |
| SG (1) | SG11202104348XA (es) |
| TW (1) | TW202031645A (es) |
| WO (1) | WO2020089262A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12358901B2 (en) | 2018-10-16 | 2025-07-15 | Autifony Therapeutics Limited | KV3 modulators |
| US20220220095A1 (en) * | 2019-04-26 | 2022-07-14 | H. Lundbeck A/S | N-((HETEROARYL)METHYL)-1-TOSYL-1H-PYRAZOLE-3-CARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS |
| WO2023017263A1 (en) | 2021-08-10 | 2023-02-16 | Autifony Therapeutics Limited | Potassium channel modulators |
| EP4630117A1 (en) | 2022-12-06 | 2025-10-15 | Autifony Therapeutics Limited | Compounds for the treatment of centra nervous system disorders |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010531841A (ja) * | 2007-07-04 | 2010-09-30 | ノイロサーチ アクティーゼルスカブ | カリウムチャネル調節剤として有用な新規なピラゾール誘導体 |
| TW201028421A (en) * | 2009-01-15 | 2010-08-01 | Abbott Lab | Novel benzenesulfonamides as calcium channel blockers |
| WO2011073276A1 (en) * | 2009-12-16 | 2011-06-23 | Evotec Ag | Benzoxazine aryl sulfonamide derivatives as kv1.3 modulators |
| WO2011073269A1 (en) * | 2009-12-16 | 2011-06-23 | Evotec Ag | Piperidine aryl sulfonamide derivatives as kv1.3 modulators |
| US9290485B2 (en) * | 2010-08-04 | 2016-03-22 | Novartis Ag | N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides |
| FR2967674B1 (fr) * | 2010-11-23 | 2012-12-14 | Pf Medicament | Derives d'heteroarylsulfonamides, leur preparation et leur application en therapeutique humaine |
| US9085583B2 (en) * | 2012-02-10 | 2015-07-21 | Constellation—Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| CN104334547B (zh) * | 2012-05-22 | 2017-06-06 | 奥蒂福尼疗法有限公司 | 作为kv3抑制剂的三唑类 |
| GB201521751D0 (en) * | 2015-12-10 | 2016-01-27 | Autifony Therapeutics Ltd | Novel uses |
| GB201522179D0 (en) * | 2015-12-16 | 2016-01-27 | Autifony Therapeutics Ltd | Novel compounds |
| GB201613163D0 (en) * | 2016-07-29 | 2016-09-14 | Autifony Therapeutics Ltd | Novel compounds |
-
2019
- 2019-10-29 AR ARP190103138A patent/AR116898A1/es not_active Application Discontinuation
- 2019-10-29 TW TW108139051A patent/TW202031645A/zh unknown
- 2019-10-29 US US16/667,563 patent/US20200131156A1/en not_active Abandoned
- 2019-10-30 CR CR20210285A patent/CR20210285A/es unknown
- 2019-10-30 PH PH1/2021/550957A patent/PH12021550957A1/en unknown
- 2019-10-30 KR KR1020217015490A patent/KR20210086661A/ko not_active Withdrawn
- 2019-10-30 BR BR112020013011-7A patent/BR112020013011A2/pt not_active Application Discontinuation
- 2019-10-30 WO PCT/EP2019/079587 patent/WO2020089262A1/en not_active Ceased
- 2019-10-30 EP EP19798210.1A patent/EP3873891A1/en not_active Withdrawn
- 2019-10-30 JO JOP/2021/0091A patent/JOP20210091A1/ar unknown
- 2019-10-30 PE PE2021000636A patent/PE20211975A1/es unknown
- 2019-10-30 MA MA054061A patent/MA54061A/fr unknown
- 2019-10-30 JP JP2021547926A patent/JP2022509416A/ja active Pending
- 2019-10-30 SG SG11202104348XA patent/SG11202104348XA/en unknown
- 2019-10-30 CN CN201980071046.3A patent/CN113056461A/zh active Pending
- 2019-10-30 EA EA202190899A patent/EA202190899A1/ru unknown
- 2019-10-30 MX MX2021004935A patent/MX2021004935A/es unknown
- 2019-10-30 AU AU2019373367A patent/AU2019373367A1/en not_active Abandoned
- 2019-10-30 CA CA3116273A patent/CA3116273A1/en not_active Abandoned
-
2021
- 2021-04-26 IL IL282639A patent/IL282639A/en unknown
- 2021-04-28 CO CONC2021/0005579A patent/CO2021005579A2/es unknown
- 2021-04-29 DO DO2021000081A patent/DOP2021000081A/es unknown
- 2021-04-29 CL CL2021001123A patent/CL2021001123A1/es unknown
- 2021-05-28 EC ECSENADI202138534A patent/ECSP21038534A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12021550957A1 (en) | 2022-05-02 |
| EP3873891A1 (en) | 2021-09-08 |
| SG11202104348XA (en) | 2021-05-28 |
| EA202190899A1 (ru) | 2021-08-19 |
| CR20210285A (es) | 2021-09-16 |
| PE20211975A1 (es) | 2021-10-05 |
| AU2019373367A1 (en) | 2021-05-27 |
| JP2022509416A (ja) | 2022-01-20 |
| CL2021001123A1 (es) | 2021-10-22 |
| BR112020013011A2 (pt) | 2021-05-04 |
| MX2021004935A (es) | 2021-06-08 |
| WO2020089262A1 (en) | 2020-05-07 |
| KR20210086661A (ko) | 2021-07-08 |
| CN113056461A (zh) | 2021-06-29 |
| DOP2021000081A (es) | 2021-07-30 |
| ECSP21038534A (es) | 2021-06-30 |
| CO2021005579A2 (es) | 2021-05-10 |
| IL282639A (en) | 2021-06-30 |
| CA3116273A1 (en) | 2020-05-07 |
| US20200131156A1 (en) | 2020-04-30 |
| MA54061A (fr) | 2021-12-15 |
| TW202031645A (zh) | 2020-09-01 |
| JOP20210091A1 (ar) | 2023-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR116898A1 (es) | DERIVADOS DE ARILSULFONILPIRROLCARBOXAMIDA COMO ACTIVADORES DE CANALES DE POTASIO Kv3 | |
| AR107061A1 (es) | Heteroarilhidroxipirimidinonas como agonistas del receptor de apj | |
| AR110405A1 (es) | Compuestos | |
| AR098311A1 (es) | Compuestos para el control de artrópodos | |
| AR107973A1 (es) | 6-hidroxi-4-oxo-1,4-dihidropirimidin-5-carboxamidas como agonista de apj | |
| AR109349A1 (es) | Compuestos y usos | |
| AR103232A1 (es) | ANTAGONISTAS DE TGFbR | |
| AR110282A1 (es) | Compuestos de amida bicíclica y uso de éstos en el tratamiento de enfermedades mediadas por rip1 | |
| AR119971A1 (es) | Derivados de piridazin-3(2h)-ona fusionados con azol | |
| EA202191991A1 (ru) | Новые производные гетеротрициклического соединения и их применение | |
| AR119657A1 (es) | Compuestos de pirimidina y composiciones farmacéuticas para prevenir o tratar cánceres que incluyen los mismos | |
| MX383363B (es) | Compuestos macrociclicos como inhibidores de cinasas asociadas al receptor de interleucina1/4 (irak1/4) y usos de los mismos. | |
| AR108906A1 (es) | Heterociclos de biarilmetilo | |
| AR099498A1 (es) | Compuestos de triazina y su uso farmacéutico | |
| AR096846A1 (es) | Dihidroquinoxalinonas y dihidropiridopirazinonas modificadas como inhibidores de la proteína bet | |
| AR114420A1 (es) | Derivados de 2,4-diaminoquinazolina y usos médicos de los mismos | |
| AR121676A1 (es) | DERIVADOS DE BENZODIAZEPINAS COMO PAM DE GABAA g1 | |
| AR120029A1 (es) | Compuestos heterocíclicos | |
| AR116400A1 (es) | Compuesto de imidazopiridinona | |
| AR114564A1 (es) | DERIVADOS DE 2,4,6,7-TETRAHIDRO-PIRAZOLO[3,4-D]PIRIMIDIN-ONA COMO MODULADORES DEL RECEPTOR C5a Y COMPOSICIÓN FARMACÉUTICA QUE LOS COMPRENDE | |
| BR112022001922A2 (pt) | Compostos de heteroarila de anel fundido como inibidores de ripk1 | |
| AR116713A1 (es) | COMPUESTOS DE IMIDAZOLINDIONA COMO REGULADORES DE CANALES Kv3 | |
| AR100439A1 (es) | Derivados de carboxamida | |
| AR120865A1 (es) | Tieniloxazolonas y análogos utilizados en el control de enfermedades de plantas | |
| AR123241A1 (es) | Derivados de espiropiperidinilo sustituidos con heteroarilo y usos farmacéuticos de los mismos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |